Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Acorda Therapeutics Inc ACORQ

Healthcare Biotechnology
Acorda Therapeutics, Inc. is a biopharmaceutical company focused on developing therapies that restore function and improve the lives of people with neurological disorders. The Company markets Inbrija (levodopa inhalation powder), which is approved in the United States for intermittent treatment of OFF episodes, also known as OFF periods, in people with Parkinson’s disease treated with carbidopa... see more

Recent & Breaking News (OTCPK:ACORQ)

ACORDA THERAPEUTICS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Investing In Acorda Therapeutics, Inc. To Contact The Firm

PR Newswire September 25, 2017

Acorda to Present at the Cantor Fitzgerald Global Healthcare Conference

Business Wire September 13, 2017

Stocks Under Scanner in the Biotech Space -- Acorda Therapeutics, Advaxis, Xbiotech, and Akebia Therapeutics

PR Newswire September 11, 2017

INVESTOR ALERT: Goldberg Law PC Announces an Investigation of Acorda Therapeutics, Inc.

Business Wire September 8, 2017

ACORDA THERAPEUTICS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Investing In Acorda Therapeutics, Inc. To Contact The Firm

Business Wire September 5, 2017

Acorda Adopts Shareholder Rights Plan

Business Wire September 1, 2017

SHAREHOLDER ALERT: Goldberg Law PC Announces an Investigation of Acorda Therapeutics, Inc.

Business Wire August 30, 2017

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Acorda Therapeutics Inc. (ACOR)

PR Newswire August 30, 2017

Acorda Therapeutics (ACOR) Alert: Shareholder Rights Law Firm J&W Investigates Acorda Therapeutics, Inc.; Encourages Investors to Contact the Firm

PR Newswire August 30, 2017

Acorda Therapeutics, Inc. Investor Alert: Legal Investigation for Potential Securities Law Violations

Business Wire August 29, 2017

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of Commencement of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Acorda Therapeutics, Inc.

Business Wire August 29, 2017

Mid-Afternoon Market Update: U.S. Stocks Turn Higher; J.Jill Shares Plummet

Benzinga.com  August 29, 2017

ACORDA THERAPEUTICS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Investing In Acorda Therapeutics, Inc. To Contact The Firm

Business Wire August 29, 2017

15 Biggest Mid-Day Losers For Tuesday

Benzinga.com  August 29, 2017

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ellie Mae, Inc. - ELLI

PR Newswire August 29, 2017

Mid-Day Market Update: Movado Rises After Strong Q2 Results; Finish Line Shares Slide

Benzinga.com  August 29, 2017

INVESTOR ALERT: Investigation of Acorda Therapeutics Announced by Holzer & Holzer

Business Wire August 29, 2017

Mid-Morning Market Update: Markets Open Lower; Best Buy Tops Q2 Estimates

Benzinga.com  August 29, 2017

25 Stocks Moving In Tuesday's Pre-Market Session

Benzinga.com  August 29, 2017

Acorda Receives Refusal to File Letter from FDA for INBRIJA™ (CVT-301, levodopa inhalation powder) New Drug Application

Business Wire August 29, 2017